SEARCH FIRM NEWS
FDA dropped the amended Part 820 Rule on Feb. 2. Evan Phelps suggests medical device manufacturers look at their processes, procedures, and documentation and prepare to comply in the next two years.
Three attorneys in the firm were recognized for outstanding work in their practice areas in the latest edition of Super Lawyers. Amin Wasserman Gurnani is grateful to have these 2024 Illinois Rising Stars on our team:
For a story reported by NutraIngredients’ Danielle Masterson, Ivan Wasserman discussed the burgeoning weight loss medication category and how comparing supplements to drugs could land companies in hot water.
HBW Insight turned to Lauren Aronson for insight into online marketing practices that will be on the regulatory radar in 2024.
MedTech Insight turned to Neil O’Flaherty and Evan Phelps to discuss FDA hot topics to watch out for in 2024. Our medical device team touched on the following areas:
Just before the original Dec. 29, 2023, deadline for cosmetic product listings and facility registration, FDA released the new and improved FDA CDER Direct & Cosmetics Direct portal. The portal is accessible at https://direct.fda.gov/.
With a dizzying docket of cases still dancing in his head, amid claims and class actions, oceans of motions, judges and juries, and suits still to settle, Matthew Orr presents the 2023 Top Ten List of Too Many Lawsuits in our latest Amin In a Minute video.
Ivan Wasserman spoke with New Hope Network’s Melania Juntti about the Dietary Supplement Health and Education Act (DSHEA), which can be confusing and complicated.
The California Air Resources Board is conducting a consumer products survey. All companies selling products within 37 selected categories are required to complete the survey based on their 2023 sales into California.
see all news >